Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.24% |
| 2 | Financials | 5.68% |
| 3 | Healthcare | 5.62% |
| 4 | Consumer Discretionary | 5.04% |
| 5 | Industrials | 3.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3301
Rush Enterprises Class A
RUSHA
$9.62B
| $1.32M | ﹤0.01% |
75,706
+45,160
| +148% | +$862K |
|
|
MSGN
3302
DELISTED
MSG Networks Inc.
MSGN
| $1.32M | ﹤0.01% |
51,295
+25,009
| +95% | +$600K |
|
3303
CALL
Thor Industries
THO
$4.11B
| $1.32M | ﹤0.01% |
15,800
-41,400
| -72% | -$3.96M |
|
|
SGMO
3304
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $1.32M | ﹤0.01% |
77,974
-41,765
| -35% | -$635K |
|
|
TPIC
3305
DELISTED
TPI Composites
TPIC
| $1.32M | ﹤0.01% |
46,261
+28
| +0.1% | +$811 |
|
3306
Buckle
BKE
$2.31B
| $1.31M | ﹤0.01% |
57,078
+17,659
| +45% | +$435K |
|
3307
City Holding Co
CHCO
$2.08B
| $1.31M | ﹤0.01% |
17,112
+11,498
| +205% | +$914K |
|
3308
Pilgrim's Pride
PPC
$6.57B
| $1.31M | ﹤0.01% |
72,628
-74,235
| -51% | -$1.37M |
|
3309
Coherus Oncology
CHRS
$176M
| $1.31M | ﹤0.01% |
79,571
+56,954
| +252% | +$1.01M |
|
3310
Kforce
KFRC
$1.08B
| $1.31M | ﹤0.01% |
34,849
+9,273
| +36% | +$365K |
|
3311
PUT
United Parks & Resorts
PRKS
$2.04B
| $1.31M | ﹤0.01% |
41,700
-151,500
| -78% | -$3.95M |
|
|
HOUS
3312
PUT
DELISTED
Anywhere Real Estate
HOUS
| $1.31M | ﹤0.01% |
63,400
-4,100
| -6% | -$89.3K |
|
3313
IAMGOLD
IAG
$10.1B
| $1.31M | ﹤0.01% |
356,052
+273,807
| +333% | +$1.3M |
|
3314
Valmont Industries
VMI
$9.5B
| $1.31M | ﹤0.01% |
9,449
+4,613
| +95% | +$649K |
|
3315
MaxLinear
MXL
$6.95B
| $1.31M | ﹤0.01% |
65,803
+31,634
| +93% | +$576K |
|
3316
PUT
Tapestry
TPR
$25.9B
| $1.31M | ﹤0.01% |
26,000
-4,400
| -14% | -$215K |
|
|
WMGI
3317
PUT
DELISTED
Wright Medical Group Inc
WMGI
| $1.31M | ﹤0.01% |
+45,000
| New | +$1.21M |
|
|
WP
3318
PUT
DELISTED
Worldpay, Inc.
WP
| $1.31M | ﹤0.01% |
12,900
-800
| -6% | -$73.1K |
|
3319
USA Compression Partners
USAC
$3.78B
| $1.3M | ﹤0.01% |
78,997
+71,675
| +979% | +$1.21M |
|
3320
Andersons Inc
ANDE
$2.21B
| $1.3M | ﹤0.01% |
34,600
+24,297
| +236% | +$916K |
|
3321
Coca-Cola Consolidated
COKE
$12.7B
| $1.3M | ﹤0.01% |
71,490
+53,480
| +297% | +$857K |
|
3322
Comtech Telecommunications
CMTL
$52.7M
| $1.3M | ﹤0.01% |
35,865
+3,513
| +11% | +$120K |
|
3323
PUT
Truist Financial
TFC
$64.7B
| $1.3M | ﹤0.01% |
26,800
+7,200
| +37% | +$369K |
|
|
BPYU
3324
DELISTED
Brookfield Property REIT Inc. Class A Common Stock
BPYU
| $1.3M | ﹤0.01% |
+62,108
| New | +$1.25M |
|
3325
PUT
Ovintiv
OVV
$17.2B
| $1.3M | ﹤0.01% |
19,820
+5,300
| +37% | +$344K |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.